Intracranial mass lesions and skin discoloration in the armpits as unusual clues to Erdheim-Chester disease: a case report
Open Access
- 18 February 2021
- journal article
- case report
- Published by Springer Nature in BMC Neurology
- Vol. 21 (1), 1-4
- https://doi.org/10.1186/s12883-021-02107-w
Abstract
Erdheim–Chester disease (ECD) is a non-Langerhans histiocytosis that results in multi-organ disease involving the skin, bones, lungs and kidneys. Central nervous system (CNS) involvement occurs in about 50 % of patients, and diabetes insipidus, visual disturbances, and cerebellar ataxia are the most frequent neurological signs. We report a case of Erdheim-Chester disease with central nervous system involvement in the form of enhancing intracranial mass lesions with massive edema. The patient presented with vertigo, ataxia, encephalopathy and pyramidal signs. Diagnosis was suggested by xanthomatous skin lesions and a biopsy was compatible with Erdheim-Chester disease demonstrating xanthogranulomas CD68 positive (clone KP1) and CD1a and S100 negative. Testing for BRAF mutation was negative, which precluded treatment with Vemurafenib. Treatment with steroids and interferon resulted in improvement of neurological signs and regression of edema on MRI. The diagnosis of Erdheim-Chester disease should be considered in intracranial mass lesions. Xanthomatous skin lesions are a clue to the diagnosis.Keywords
This publication has 8 references indexed in Scilit:
- Erdheim–Chester disease: A systematic reviewCritical Reviews in Oncology/Hematology, 2015
- Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester diseaseBlood, 2014
- Erdheim-Chester DiseaseRheumatic Disease Clinics of North America, 2013
- Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutationBlood, 2013
- The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new casesAnnals Of The Rheumatic Diseases, 2013
- Treatment of Erdheim-Chester Disease with Long-Term High-Dose Interferon-αSeminars in Arthritis and Rheumatism, 2012
- CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patientsBlood, 2011
- Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literatureZeitschrift für Neurologie, 2006